Cytokinetics | CYTK - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Acadia Pharmaceuticals USD 3.98M 22.34M 2026-03
Amgen USD 1.51B 2.41B 2025-12
Arca Biopharma USD -29.58M 694K 2025-12
Bayer EUR -3.37B 2.21B 2025-12
Biogen USD 377.7M 433.7M 2026-03
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Eisai JPY -7.94B 29.94B 2026-03
Eli Lilly USD 8.27B 1.03B 2025-12
Exelixis USD 267.69M 15M 2026-03
Geron USD -3.64M 27.5M 2026-03
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Ionis Pharmaceuticals USD -93M 135M 2026-03
Ligand Pharmaceuticals USD 56.78M 84.36M 2025-12
Merck USD 3.42B 3.32B 2025-12
Novartis USD 3.84B 802M 2026-03
Pfizer USD 5.18B 6.82B 2026-03
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12